FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/059755 [Registered on: 13/11/2023] Trial Registered Prospectively
Last Modified On: 09/11/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to compare efficacy of Nutri Leha as against Ready to Use Therapeutic Food in Karshya Severe Acute Malnutrition in children 
Scientific Title of Study   Assessment of comparative efficacy of Nutri Leha as against Ready to Use Therapeutic Food RUTF in management of Karshya Severe Acute Malnutrition in children Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Klita Maxim Pereira 
Designation  PG SCHOLAR 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Room no 41 Department of Kaumarabhritya Mahatma Gandhi Ayurved College Hospital and Research Centre Hirapur Salod Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9967902890  
Fax    
Email  klitapereira02@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Klita Maxim Pereira 
Designation  PG SCHOLAR 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Room no 41 Department of Kaumarabhritya Mahatma Gandhi Ayurved College Hospital and Research Centre Hirapur Salod Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9967902890  
Fax    
Email  klitapereira02@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Renu Rathi 
Designation  Professor 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Room no 41 Department of Kaumarabhritya Mahatma Gandhi Ayurved College Hospital and Research Centre Hirapur Salod Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9011058302  
Fax    
Email  renu.rathi@dmimsu.edu.in  
 
Source of Monetary or Material Support  
Mahatma Gandhi Ayurved College Hospital and Research Centre Hirapur Salod Wardha 
 
Primary Sponsor  
Name  Mahatma Gandhi Ayurved College Hospital and Research Centre Hirapur Salod Wardha 
Address  Room no 41 Department of Kaumarabhritya Mahatma Gandhi Ayurved College Hospital and Research Centre Hirapur Salod Wardha 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Klita Pereira  Mahatma Gandhi Ayurved College Hospital and Research Centre Hirapur Salod Wardha  Room no 41 Department of Kaumarabhritya Mahatma Gandhi Ayurved College Hospital and Research Centre Hirapur Salod Wardha
Wardha
MAHARASHTRA 
09967902890

klitapereira02@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Mahatma Gandhi Ayurved College Hospital and Research Centre  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E43||Unspecified severe protein-caloriemalnutrition. Ayurveda Condition: KARSYAM (KEVALAVATA),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Nutri leha, Reference: NA, Route: Oral, Dosage Form: Avleha/Leha/Paka/Raskriya, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information: dose will be calculated according to youngs formula as the age group is pediatric group from 6 months to 5 yrs
2Comparator Arm (Non Ayurveda)-Ready to Use Therapeutic Food dosage - 175 kcal/kg/day orally twice a day before food
 
Inclusion Criteria  
Age From  6.00 Month(s)
Age To  5.00 Year(s)
Gender  Both 
Details  Patient suffering from karshya
Children having low weight for height below -3 SD low BMI for age and children falling in grade 3 and 4 classification of PEM according to IAP 
 
ExclusionCriteria 
Details  Children having low weight for height below -3 SD low BMI for age and children falling in grade 1 and 2 classification of PEM according to IAP
Below 6 month and above 5 years
suffering from infectious diseases like TB HIV etc
Suffering from complicated severe acute malnutrition
Guardian who are not willing to give informed written consent 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess the efficacy of Nutri Leha and Ready to Use Therapeutic Food in reducing clinical features of Karshya  90 days 
 
Secondary Outcome  
Outcome  TimePoints 
Comparison & assessment of efficacy of Nutri Leha & Ready to Use Therapeutic Food on anthropometric values  3 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   20/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The volunteers will be informed about the study protocol . Willing participants will be randomly selected as per computer generated table. Clinical research format will be prepared and validated. 
Prior to study approval will be taken From IEC,MGAHRC, Salod, Wardhaand CTRI registration will be done. After selection, each participant will  be tested and selected according to the selection criteria. They are divided into two groups the trial is a  two arm parallel group, randomized, open labelled, clinical standard controlled trial. It will include a 90 days  treatment period with assessment on 15th , 30th, 45th, 60th, 75th, 90th day of treatment and follow up on 30th, 60th and 90th day post treatment. 
 
Close